Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00412074 · ClinicalTrials.gov registry record · Phase 3
Establishing the Vitamin D Requirements During Lactation
A Phase 3 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 3
- Development phase
- 460
- Enrollment target
NCT00412074 is a Phase 3 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 460 participants.
The verdict
NCT00412074, a Phase 3 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 460 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness and safety of maternal and infant vitamin D supplementation as a function of ethnicity and latitude in the prevention of vitamin D deficiency in the breastfeeding mother-infant pair. The findings of this study will generate important new information for health care professionals and policy makers with regard to vitamin D requirements and the potential benefit to both mother and infant
Interventions
- DRUG 400 IU Vitamin D3 (cholecalciferol)
- DRUG 2400 IU Vitamin D3 (cholecalciferol)
- DRUG 6400 IU Vitamin D3 (cholecalciferol)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 460 participants |
| Start Date | 2006-08 |
| Est. Completion | 2012-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00412074
The ClinicalTrials.gov registry entry for NCT00412074 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 460 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which 400 IU Vitamin D3 (cholecalciferol) is the first listed.
NCT00412074 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00412074 about?
NCT00412074 is a clinical study titled "Establishing the Vitamin D Requirements During Lactation". The purpose of this study is to determine the effectiveness and safety of maternal and infant vitamin D supplementation as a function of ethnicity and latitude in the prevention of vitamin D deficiency in the breastfeeding mother-infant pair. The findings of this study will generate important new in...
What is the current status of trial NCT00412074?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 460 participants. The study started on 2006-08. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00412074?
The interventions under investigation include: 400 IU Vitamin D3 (cholecalciferol) (DRUG), 2400 IU Vitamin D3 (cholecalciferol) (DRUG), 6400 IU Vitamin D3 (cholecalciferol) (DRUG).
Who is sponsoring clinical trial NCT00412074?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.